Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Abl Y486-p
AMPKA1 T401-p
ATM S113-p
ERK1 S405-p , S418-p
ERK2 S405-p , S418-p
Fyn Y421-p , Y446-p , Y453-p , Y470-p , Y486-p
PAK1 S113-p , S405-p , S418-p
PKCD S405-p
PKCI S261-p
PRKD1 S298-p , S348-p
PRKD2 S298-p
PRKD3 S298-p
Pyk2 Y421-p , Y470-p , Y486-p
Src Y334-p , Y470-p
Syk Y421-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

AMPKA1 T401-p
ATM S113-p
CDK1 S405-p
CDK2 S405-p
Chk1 S298-p
ERK1 S405-p , S418-p
ERK2 S405-p , S418-p
PAK1 S405-p , S418-p
PKCI S261-p
PRKD1 S298-p , S348-p
Pyk2 Y421-p , Y470-p , Y486-p
Src Y470-p , Y486-p
Phosphatases, in vitro:
PTP1B Y446-p
Regulatory protein:
Abl Y421-p
Arg Y421-p
CCL13 S405-p , S418-p
CCR2 S405-p , S418-p , Y421-p , Y446-p , Y453-p , Y470-p , Y486-p
GIT1 S405-p
KDELR1 Y421-p
PLCB3 S405-p , S418-p
PPP1CA Y421-p , Y446-p , Y453-p , Y470-p , Y486-p
PPP2CA Y421-p , Y446-p , Y453-p , Y470-p , Y486-p
PRKD1 S298-p
PRP4 T399-p , T401-p , S418-p
RBM17 S405-p , S418-p
Src S298-p , S348-p
Src S298-p , S348-p
STMN1 Y421-p
Treatment:
angiotensin_2 T399-p , T401-p , S405-p , S418-p
anti-CD3 S418-p , Y421-p
bacterial infection S405-p , S418-p , Y470-p
BAPTA-AM Y421-p , Y446-p , Y453-p , Y470-p , Y486-p
BI2536 S426-p
curcumin Y421-p
dasatinib T401-p , S405-p
EGF T399-p , S405-p , S418-p , Y421-p , Y446-p
EGTA S298-p
ephrin_B1 Y154-p , Y178-p , Y228-p , Y334-p , T399-p , T401-p , S405-p , Y421-p , Y446-p
ephrin_B2 S418-p , Y421-p , Y446-p
erlotinib Y178-p , Y302-p , S418-p , Y421-p
Escherichia_coli_lysate Y470-p
FGF2 T401-p , Y421-p , Y446-p
gefitinib Y104-p , Y289-p , Y446-p
Go_6976 S298-p , S348-p
HGF Y421-p , Y446-p
hypoxia S113-p
imatinib S405-p , S418-p , Y421-p
ischemia S11-p , S47-p , S150-p , S261-p , S277-p , S282-p , T401-p , S405-p , T411-p , S432-p , S447-p
KU-60019 S113-p
laminin peptide Y470-p
lapatinib T401-p , S405-p , Y421-p
lisuride S447-p
LRRK2-IN-1 S405-p
metastatic potential T401-p , S405-p , S418-p
MG132_withdrawal S418-p
MS275 K87-ac , K144-ac , K198-ac , K218-ac , K272-ac , K309-ac
nocodazole S261-p , T399-p , T401-p , S405-p , S417-p , S418-p
PD98059 S405-p , S418-p
phorbol_ester S298-p , S348-p
PP2 Y470-p
PTP1B_inhibitor Y421-p , Y446-p
PTX Y421-p , Y446-p , Y453-p , Y470-p , Y486-p
saracatinib S405-p , S418-p
selumetinib T401-p , S405-p , S417-p , S418-p
serum S405-p , S418-p
SII_angiotensin_2 T399-p
siRNA S113-p , S405-p , S418-p , Y486-p
sphingosine_1-phosphate Y486-p
Su11274 Y104-p , Y154-p , Y178-p , Y215-p , Y334-p , Y421-p , Y433-p , Y446-p , Y453-p
sucrose Y421-p , Y446-p
thrombin Y446-p
U0126 T399-p , T401-p , S405-p , S418-p , S447-p
VEGF S405-p
vemurafenib T401-p , S405-p , S417-p , S418-p
vorinostat K87-ac , K309-ac